Company Overview of mAbxience SA
mAbxience SA operates as a biopharmaceutical company that researches, develops, and manufactures biosimilars compounds for the treatment and/or prevention of various diseases in therapeutic areas. The company also offers technical transfer support and regulatory services. It provides its products and services to the pharmaceutical market worldwide. The company is based in Lugano, Switzerland with a production facility in Buenos Aires, Argentina. It also has a location in Montevideo, Uruguay; and a development and production facility in Leon, Spain. mAbxience SA operates as a subsidiary of Chemo Iberica, S.A.
Via Maggio, 1
41 91 973 14 23
Key Executives for mAbxience SA
mAbxience SA Key Developments
Similar Private Companies By Industry
|AB2 Bio Ltd.||Europe|
|ADC Products Switzerland SARL||Europe|
|ADC Therapeutics SA||Europe|
|AlloCyte Pharmaceuticals AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact mAbxience SA, please visit www.mabxience.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.